Search company, investor...

Stage

Unattributed | Alive

Total Raised

$710K

Last Raised

$250K | 7 yrs ago

About EVELO

EVELO is a company that specializes in the design and production of electric bicycles, operating within the electric vehicle and cycling industries. The company offers a range of electric bikes equipped with advanced features such as mid-drive motors, CVT shifting systems, and carbon belt drivetrains, designed to make cycling accessible and enjoyable for all riders. EVELO primarily serves the consumer market, with a focus on recreational, commuting, and exercise use. It is based in Rockaway Park, New York.

Headquarters Location

327 Beach 101st Street

Rockaway Park, New York, 11694,

United States

877-991-7272

Loading...

Loading...

Expert Collections containing EVELO

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

EVELO is included in 2 Expert Collections, including Auto Tech.

A

Auto Tech

3,931 items

Companies working on automotive technology, which includes vehicle connectivity, autonomous driving technology, and electric vehicle technology. This includes EV manufacturers, autonomous driving developers, and companies supporting the rise of the software-defined vehicles.

B

Bike & Scooter Tech

333 items

We define bike and scooter technology startups as companies working on shared vehicle networks, vehicle design, and charging infrastructure for bicycles, scooters, mopeds, and other compact vehicles for one to two passengers.

Latest EVELO News

Psoriatic Arthritis Pipeline Insights Report 2024 | Mylan, Celltrion, Fresenius Kabi, Pfizer, Fujifilm Kyowa Kirin Biologics,Amgen, Zydus cedilla, Sandoz, Shanghai Henlius Biotech and others

Feb 19, 2024

DelveInsight’s, “Psoriatic Arthritis Pipeline Insight 2024” report provides comprehensive insights about 50+ Psoriatic Arthritis companies and 50+ pipeline drugs in the Psoriatic Arthritis pipeline landscape. It covers the Psoriatic Arthritis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Psoriatic Arthritis therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key Takeaways from the Psoriatic Arthritis Pipeline Report DelveInsight’s Psoriatic Arthritis pipeline report depicts a robust space with 50+ Psoriatic Arthritis companies working to develop 50+ pipeline therapies for Psoriatic Arthritis treatment. The leading companies working in the Psoriatic Arthritis Market include Mylan, Celltrion, Fresenius Kabi, Pfizer, Fujifilm Kyowa Kirin Biologics, Amgen, Zydus cedilla, Sandoz, Shanghai Henlius Biotech, Hetero Biopharma, CinnaGen, Fresenius Kabi, Torrent Pharmaceuticals, Cipla, Biogen, AbbVie, Biocad, Boehringer Ingelheim, Sun Pharma Global, Gilead Sciences, UCB Biopharma, Formycon, Bristol-Myers Squibb, AbGenomics, Boehringer Ingelheim, Affibody, AltruBio, Bio-Thera Solutions, Dong-A ST, Synact Pharma, NeuClone, 3SBio, Qyuns Therapeutics, Kangpu Biopharmaceuticals, Alpine Immune Sciences, Akeso Biopharma, Polpharma Biologics, Avotres, Bio-Thera Solutions, Xbrane Biopharma, XBiotech, Innovimmune Biotherapeutics, Aclaris Therapeutics, Luye Pharma Group, Evelo, Levolta Pharmaceuticals, DNX Biopharmaceuticals, Mycenax Biotech, and others. Promising Psoriatic Arthritis Pipeline Therapies in the various stages of development include NDI-034858, Alefacept, Methotrexate, Etanercept, UCB4940 40 mg, Methotrexate (MTX), and others. September 2023: ACELYRIN Inc. announced a study of phase 2 & 3 clinical trials for Izokibep. Izokibep is a potent and selective inhibitor of interleukin (IL)-17A that is being developed for treatment of psoriatic arthritis (PsA). This study will evaluate the efficacy of izokibep in subjects with PsA. September 2023: Novartis Pharmaceuticals announced a study of phase 3 clinical trials for Secukinumab and Ustekinumab. The purpose of this study is to compare the safety and efficacy of secukinumab and ustekinumab in patients with active psoriatic arthritis who showed failure to previous TNFα-inhibitor treatment. Request a sample and discover the recent advances in Psoriatic Arthritis Treatment Drugs @  Psoriatic Arthritis Pipeline Report In the Psoriatic Arthritis pipeline report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Psoriatic Arthritis collaborations, licensing, mergers and acquisition, funding, designations and other product related details. Psoriatic Arthritis Overview Psoriatic Arthritis is a chronic inflammatory disease of the joints that can be associated with the psoriasis. It can affect both peripheral joints and axial skeleton causing pain, stiffness, swelling and joint destruction. This joint pathology develops gradually and cause more nuisance than disabling. Psoriatic arthritis is considered as seronegative spondyloarthropathies. ABT-494: AbbVie Psoriatic ArthritisTherapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III Psoriatic Arthritis Companies- Mylan, Celltrion, Fresenius Kabi, Pfizer, Fujifilm Kyowa Kirin Biologics, Amgen, Zydus cedilla, Sandoz, Shanghai Henlius Biotech, Hetero Biopharma, CinnaGen, Fresenius Kabi, Torrent Pharmaceuticals, Cipla, Biogen, AbbVie, Biocad, Boehringer Ingelheim, Sun Pharma Global, Gilead Sciences, UCB Biopharma, Formycon, Bristol-Myers Squibb, AbGenomics, Boehringer Ingelheim, Affibody, AltruBio, Bio-Thera Solutions, Dong-A ST, Synact Pharma, NeuClone, 3SBio, Qyuns Therapeutics, Kangpu Biopharmaceuticals, Alpine Immune Sciences, Akeso Biopharma, Polpharma Biologics, Avotres, Bio-Thera Solutions, Xbrane Biopharma, XBiotech, Innovimmune Biotherapeutics, Aclaris Therapeutics, Luye Pharma Group, Evelo, Levolta Pharmaceuticals, DNX Biopharmaceuticals, Mycenax Biotech, and others. Psoriatic Arthritis Pipeline Therapies- NDI-034858, Alefacept, Methotrexate, Etanercept, UCB4940 40 mg, Methotrexate (MTX), and others.

EVELO Frequently Asked Questions (FAQ)

  • Where is EVELO's headquarters?

    EVELO's headquarters is located at 327 Beach 101st Street, Rockaway Park.

  • What is EVELO's latest funding round?

    EVELO's latest funding round is Unattributed.

  • How much did EVELO raise?

    EVELO raised a total of $710K.

  • Who are the investors of EVELO?

    Investors of EVELO include Forefront Venture Partners.

  • Who are EVELO's competitors?

    Competitors of EVELO include VanMoof and 7 more.

Loading...

Compare EVELO to Competitors

Cowboy Logo
Cowboy

Cowboy develops electric bikes for urban riders. It focuses to improve urban mobility and take commuters to their destination in a sustainable manner. Its product offerings include Cowboy 4, Cowboy 4 ST, and Cowboy 3. The company was founded in 2017 and is based in Brussels, Belgium.

Ubco Logo
Ubco

Ubco manufactures electric bikes. It offers a dual electric drive utility bike that is a lightweight, near-connected utility vehicle. It offers features such as silent motors, 100km battery life, and full recharge in six hours. It was founded in 2015 and is based in the Bay of Plenty, New Zealand.

Civilized Cycles Logo
Civilized Cycles

Civilized Cycles is a company that focuses on the design and production of electric bikes, operating within the transportation and technology sectors. The company's main product is a patented electric bike that combines the comfort and utility of a scooter with the ease of use of a bicycle, offering a versatile and efficient mode of transportation. The company primarily targets urban dwellers seeking an alternative to cars and public transportation, as well as suburbanites looking to reduce their car use while still requiring space for passengers or cargo. It is based in Portland, Oregon.

C
Coleen

Coleen manufactures electric bikes. It offers different kinds of electric bikes to its customers. It was founded in 2014 and is based in Biarritz, France.

A
Aventon

Aventon develops electronic bikes and biking equipment and components. It offers equipment such as batteries, chains, displays, pumps, locks, and more. The company was founded in 2012 and is based in Brea, California.

Pure Electric Logo
Pure Electric

Pure Electric is a company focused on revolutionizing urban travel, operating within the electric micro-mobility industry. The company offers electric scooters and e-bikes, designed to reduce pollution, travel time, congestion, and expensive fares in cities. These products are primarily targeted towards urban dwellers seeking sustainable and efficient transportation solutions. It was founded in 2018 and is based in Bristol, England.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.